期刊文献+

血清sFlt-1、PIGF和补体系统激活因子水平预测孕中期孕妇子痫前期发病的价值 被引量:3

Serum sFlt-1,PIGF and complement system activators in predicting preeclampsia in second trimester pregnant women
下载PDF
导出
摘要 目的探讨血清可溶性胎盘血管内皮生长因子受体-1(sFlt-1)、胎盘生长因子(PIGF)和补体系统激活因子水平预测孕中期(20~26周)孕妇子痫前期(PE)发病的价值。方法选取2018年6月至2020年6月嘉兴市妇幼保健院产科就诊的至少有1项PE危险因素的孕中期孕妇300例,将发展为PE的46例设为发病组,剩下254例设为未发病组。比较两组孕妇sFlt-1、PIGF、sFlt-1/PIGF、补体3(C3)和B因子水平,并采用ROC曲线评估各项血清指标预测PE的效能。结果发病组孕妇血清s Flt-1、sFlt-1/PIGF、C3和B因子水平均高于未发病组,PIGF水平低于未发病组,差异均有统计学意义(均P<0.01)。ROC曲线显示,sFlt-1、PIGF、sFlt-1/PIGF、C3和B因子预测PE的AUC分别为0.662、0.771、0.789、0.643和0.691,在对PE的预测中sFlt-1/PIGF效能最佳,其截断值为3.4,灵敏度和特异度分别为0.859、0.771。结论PE孕妇机体内sFlt-1、PIGF、sFlt-1/PIGF、C3和B预测PE因子存在异常,对PE的预测具有一定价值。 Objective To investigate the value of serum soluble fms-like tyrosine kinase-1(sFlt-1),placental growth factor(PIGF)and complement system activators in predicting preeclampsia(PE)in second trimester(20-26 weeks)pregnant women.Methods Three hundred pregnant women in the second trimester with at least one PE risk factor who visited the Department of Obstetrics of Jiaxing Maternal and Child Health Hospital from June 2018 to June 2020 were enrolled.Among them,PE developed in 46 cases(PE group),and the remaining 254 cases were set as non-PE group.The levels of sFlt-1,PIGF,sFlt-1/PIGF,C3 and factor B were compared between the two groups,and the ROC curve was used to evaluate the efficacy of these indicators in predicting PE in second trimester pregnant women.Results Serum levels of sFlt-1,sFlt-1/PIGF,C3 and factor B in the PE group were higher than those in the non-PE group,and PIGF level was lower than that in the non-PE group(all P<0.01).The ROC curve showed that AUC of sFlt-1,PIGF,sFlt-1/PIGF,C3 and factor B were 0.662,0.771,0.789,0.643 and 0.691,respectively.In the prediction of PE,sFlt-1/PIGF had the best performance,with a cut-off value of 3.4,and a sensitivity and specificity of 0.859 and 0.771,respectively.Conclusion The abnormality of sFlt-1,PIGF,sFlt-1/PIGF,C3 and factor B in PE pregnant women has certain value in the prediction of PE.
作者 曹云飞 马蔷 孙丹丹 黄萍华 CAO Yunfei;MA Qiang;SUN Dandan;HUANG Pinghua(Department of Obstetrics,Jiaxing Maternal and Child Health Hospital,Jiaxing 314000,China;不详)
出处 《浙江医学》 CAS 2022年第15期1624-1626,1631,共4页 Zhejiang Medical Journal
基金 浙江省基础公益性研究计划项目(LGF20H040011) 嘉兴市科技计划(公益性研究计划)项目(2018AY32020)。
关键词 子痫前期 可溶性胎盘血管内皮生长因子受体-1 胎盘生长因子 补体系统 Preeclampsia Soluble fms-like tyrosine kinase-1 Placental growth factor Complement system
  • 相关文献

参考文献9

二级参考文献72

  • 1杨孜,王伽略,黄萍,石凌懿,李蓉,叶蓉华,陈蕾.重度子癎前期终末器官受累不平行性及其围产结局探讨[J].中华围产医学杂志,2006,9(1):10-14. 被引量:109
  • 2聂良华,沈其君.产前筛查试验中MOM方法的原理及其应用[J].中国医院统计,2006,13(4):302-304. 被引量:14
  • 3Wright JD, Pawar N, Gonzalez JS, et al. Scientific evidence un- derlying the American College of Obstetricians and Gynecolo- gists practice bulletins[J]. Obstet Gynecol, 2011, 118(3):505- 512. 被引量:1
  • 4Perfetto P, Siddiqui D, Niederhauser A, et al. American College of Obstetricians and Gynecologists Practice Bulletins: original versus revised[J]. Am J Perinatol, 2010,27(8): 611-618. 被引量:1
  • 5Bramham K, Nelson-Piercy C, Brown MJ, et al. Postpartum man- agement of hypertension[J]. BMJ, 2013,346(25):f894. 被引量:1
  • 6ACOG Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period[J]. Obstet Gynecol, 2015,125(2) : 521-525. 被引量:1
  • 7Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the man- agement of hypertensive disorders of pregnancy 2008[J]. Aust N Z J Obstet Gynaecol, 2009,49(3) : 242-246. 被引量:1
  • 8Magee LA, Helewa M, Moutquin JM, et al. Diagnosis, evalua- tion, and management of the hypertensive disorders of pregnan- cy [J]. J Obstet Gynaecol Can, 2008,30(3 Suppl) : S1-S48. 被引量:1
  • 9American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnan- cy. Report of the American College of Obstetricians and Gyne- cologists' Task Force on hypertension in pregnancy[J]. Obstet Gynecol, 2013,122(5): 1122-1131. 被引量:1
  • 10Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014 [J]. Aust N Z J Obstet Gynaecol,2015,55(1): 11-16. 被引量:1

共引文献556

同被引文献27

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部